[{"orgOrder":0,"company":"TOA EIYO","sponsor":"Astellas Pharma","pharmaFlowCategory":"D","therapeuticArea":"Cardiology\/Vascular Diseases","country":"","productType":"Small molecule","year":"2021","type":"Termination","leadProduct":"Isosorbide Dinitrate","moa":"","graph1":"Cardiology\/Vascular Diseases","graph2":"Approved","graph3":"TOA EIYO","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Cardiovascular Diseases","amount2New":0,"dosageForm":"White Transluscence tape","sponsorNew":"TOA EIYO \/ Astellas","highestDevelopmentStatusID":"12","companyTruncated":"TOA EIYO \/ Astellas"}]

Find Clinical Drug Pipeline Developments & Deals for Isosorbide Dinitrate

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          Compamed
                          Not Confirmed
                          Compamed
                          Not Confirmed

                          Details : In accordance with this agreement TOA EIYO will independently sell and provide information on all 18 products such as Bisono® tape for treatment of hypertension and atrial fibrillation and Frandol® tablets and tape for treatment of ischemic heart disea...

                          Brand Name : Frandol

                          Molecule Type : Small molecule

                          Upfront Cash : Undisclosed

                          April 05, 2021

                          Lead Product(s) : Isosorbide Dinitrate

                          Therapeutic Area : Cardiology/Vascular Diseases

                          Highest Development Status : Approved

                          Sponsor : Astellas Pharma

                          Deal Size : Undisclosed

                          Deal Type : Termination

                          blank